Introduction/Background*To investigate the feasibility and acceptance of the Mika health app by patients with cancer.
Methodology Prospective intra-individually controlled pilot study. Patients were randomly assigned to receive either digital psycho-oncological support in the form of the app or standard care.
Result(s)*A total of 70 patients were included, one-third of whom had high levels of psychological distress. Relative to the baseline during the 12-week period, the mean depression score decreased in the intervention group (p = 0.00078 one-tailed, p = 0.0016 two-tailed), without any changes in the control group. The most prevalent disease-specific side effect was fatigue, which decreased by 23.1% in the intervention group and by 31.1% in the chemotherapy subgroup (p = 0.02).
Conclusion*The digital app showed high acceptance and satisfaction among patients with gynaecological malignancies, regardless of age group.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.